The Ministry of Economy’s Foreign Trade Administration and its Economic & Trade Affairs Mission in Washington, D.C., in partnership with the Israel Innovation Authority, are pleased to invite you to a webinar covering U.S. regulations on genome editing and related products.
Date: September 23, 2020
Time: 17:00 (Israel)
Registration: Zoom Registration
Expert Speaker: Emily Marden
To present us with information on the United States’ regulations and regulatory environment, we will be joined by Emily Marden, who is counsel in Sidley Austin’s Food and Drug Regulatory group. Emily trained in the life sciences and has a deep understanding of the emerging science shaping therapeutic products, agriculture, foods, and dietary supplements. Emily’s practice focuses on regulatory and strategic questions at the cutting edge, including: regenerative medicine; complex drugs and biological products; genomics and synthetic biology; regulatory exclusivity; and dietary supplements.
In addition to her regulatory practice, Emily directs research on genomics and innovation in agriculture and medicine at the University of British Columbia. Her current research focuses on the intersection of legal frameworks governing access and use of genetic resources with research. Emily earned degrees in Biology and the History of Science from Harvard University and earned her J.D. from the New York University School of Law.
After registering, you will receive a confirmation email containing information about joining the webinar.